Rhiannon Price, Pharmacist at King Edward Memorial Hospital.[/caption]
Caspar Townsend MPS, Pharmacist at Perth Children's Hospital compounding unit[/caption]
Iraq Doali, NSW-based locum pharmacist and content creator[/caption]
Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
5 changes on 1 July impacting pharmacists
All the new initiatives, funding schemes and Pharmaceutical Benefits Scheme (PBS) listings that kicked into gear on 1 July 2023.
High concentration topical capsaicin for chronic neuropathic pain
Neuropathic pain is associated with disability, reduced quality of life and employment, and increased healthcare costs.
The prevalence of neuropathic pain in the general...
SHINGRIX now available to millions of vulnerable patients
From 1 November 2023, millions of Australians at risk of severe complications from shingles can receive a Shingrix vaccine under the NIP.
Therapeutic Guidelines overhaul UTI treatment
Expansive changes have been made to the Therapeutic Guidelines on antibiotics, encompassing over 1,400 drug recommendations.
Do not supply Phenergan to children under 6, manufacturer warns
The TGA has worked with Phenergan manufacturer Sanofi to develop a new contraindication for the medicine in children under 6.
Hiprex becomes a Pharmacist Only medicine
On 1 October 2025, the TGA scheduled methenamine hippurate as a Pharmacist Only medicine to ensure pharmacist oversight of its use.
